DK575588A - Farmaceutiske praeparater til behandling af obstruktive luftvejssygdomme - Google Patents

Farmaceutiske praeparater til behandling af obstruktive luftvejssygdomme

Info

Publication number: DK575588A
Authority: DK; Denmark
Prior art keywords: vitamin; treatment; pharmaceutical preparations; obstructive airway; airway diseases
Prior art date: 1987-02-16

Application number

DK575588A

Other languages

English (en)

Other versions

DK575588D0 (da

Inventor

Willem Jacob Serfontein

Original Assignee

Knoll Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-02-16

Filing date

1988-10-14

Publication date

1988-12-08

1988-10-14 Application filed by Knoll Ag filed Critical Knoll Ag

1988-10-14 Publication of DK575588D0 publication Critical patent/DK575588D0/da

1988-12-08 Publication of DK575588A publication Critical patent/DK575588A/da

Links

230000000414 obstructive effect Effects 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
208000023504 respiratory system disease Diseases 0.000 title 1
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 14
RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 8
229940011671 vitamin b6 Drugs 0.000 abstract 7
235000019158 vitamin B6 Nutrition 0.000 abstract 4
239000011726 vitamin B6 Substances 0.000 abstract 4
235000008160 pyridoxine Nutrition 0.000 abstract 3
239000011677 pyridoxine Substances 0.000 abstract 3
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 3
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 abstract 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 2
PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 abstract 2
229960003581 pyridoxal Drugs 0.000 abstract 2
235000008164 pyridoxal Nutrition 0.000 abstract 2
239000011674 pyridoxal Substances 0.000 abstract 2
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
239000005977 Ethylene Substances 0.000 abstract 1
230000001154 acute effect Effects 0.000 abstract 1
239000003963 antioxidant agent Substances 0.000 abstract 1
230000003078 antioxidant effect Effects 0.000 abstract 1
235000006708 antioxidants Nutrition 0.000 abstract 1
235000010323 ascorbic acid Nutrition 0.000 abstract 1
229960005070 ascorbic acid Drugs 0.000 abstract 1
239000011668 ascorbic acid Substances 0.000 abstract 1
208000006673 asthma Diseases 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
238000001802 infusion Methods 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
208000030603 inherited susceptibility to asthma Diseases 0.000 abstract 1
229940127557 pharmaceutical product Drugs 0.000 abstract 1
229960002477 riboflavin Drugs 0.000 abstract 1
235000019192 riboflavin Nutrition 0.000 abstract 1
239000002151 riboflavin Substances 0.000 abstract 1
229960000278 theophylline Drugs 0.000 abstract 1
229940075420 xanthine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Compositions Of Macromolecular Compounds (AREA)

DK575588A 1987-02-16 1988-10-14 Farmaceutiske praeparater til behandling af obstruktive luftvejssygdomme DK575588A (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ZA871092		1987-02-16
ZA877704		1987-10-14
PCT/EP1988/000107 WO1988006036A1 (en)	1987-02-16	1988-02-13	Pharmaceutical compositions for treating obstructive air passage diseases

Publications (2)

Publication Number	Publication Date
DK575588D0 DK575588D0 (da)	1988-10-14
DK575588A true DK575588A (da)	1988-12-08

Family

ID=27137892

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK575588A DK575588A (da)	1987-02-16	1988-10-14	Farmaceutiske praeparater til behandling af obstruktive luftvejssygdomme

Country Status (8)

Country	Link
EP (1)	EP0302097B1 (da)
JP (1)	JPH01502666A (da)
AT (1)	ATE88635T1 (da)
AU (1)	AU1171788A (da)
DE (1)	DE3880579T2 (da)
DK (1)	DK575588A (da)
ES (1)	ES2007791A6 (da)
WO (1)	WO1988006036A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8918368D0 (en) *	1989-08-11	1989-09-20	Amco Chemie Gmbh	Compositions for treating obstructive airways disease
CN115317467B (zh) *	2022-08-22	2024-10-11	南通大学	一种用于治疗哮喘的缓释贴片及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0729927B2 (ja) *	1983-04-09	1995-04-05	日研化学株式会社	テオフィリン徐放性製剤

1988
- 1988-02-13 JP JP63501811A patent/JPH01502666A/ja active Pending
- 1988-02-13 DE DE8888901822T patent/DE3880579T2/de not_active Expired - Fee Related
- 1988-02-13 EP EP88901822A patent/EP0302097B1/en not_active Expired - Lifetime
- 1988-02-13 AT AT88901822T patent/ATE88635T1/de not_active IP Right Cessation
- 1988-02-13 WO PCT/EP1988/000107 patent/WO1988006036A1/en not_active Ceased
- 1988-02-15 ES ES8800409A patent/ES2007791A6/es not_active Expired
- 1988-02-15 AU AU11717/88A patent/AU1171788A/en not_active Abandoned
- 1988-10-14 DK DK575588A patent/DK575588A/da not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE3880579D1 (de)	1993-06-03
DE3880579T2 (de)	1993-09-16
EP0302097A1 (en)	1989-02-08
DK575588D0 (da)	1988-10-14
EP0302097B1 (en)	1993-04-28
ES2007791A6 (es)	1989-07-01
WO1988006036A1 (en)	1988-08-25
AU1171788A (en)	1988-08-18
JPH01502666A (ja)	1989-09-14
ATE88635T1 (de)	1993-05-15

Similar Documents

Publication	Publication Date	Title
SE9401406L (sv)	1994-06-07	Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
JPS5756427A (en)	1982-04-05	Medicine containing 2-phenyl-1,2-benzisoselenazole- 3(2h)-one
ATE67677T1 (de)	1991-10-15	Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
GEP20084347B (en)	2008-04-10	New derivatives of diphosphonic acid, method for their preparation and medicamentous form containing them
EP0295331A3 (en)	1989-01-04	Use of vitamin e for normalizing the blood coagulation in the therapy with omega-3-type highly unsaturated fatty acids
EP0377520A3 (en)	1991-07-17	Use of nicotine for the manufacture of a kit for the treatment of conditions susceptible to said treatment
GR861089B (en)	1986-08-26	Therapeutic application of phosponylmethoxy alkyl ademines
HU213677B (en)	1997-12-29	Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
ATE40647T1 (de)	1989-02-15	Extraktionsverfahren von propolis, danach erhaltenes wasserloesliches getrocknetes pulver aus propolis, propolisenthaltende kosmetische und pharmazeutische praeparate.
DE69210802D1 (de)	1996-06-20	Pharmazeutische aerosolzubereitung sowie deren verwendung zur behandlung und prophylaxe viraler erkrankungen
DE3062981D1 (en)	1983-06-09	Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives
EP0285856A3 (en)	1990-12-05	Use of dihydroergotamine and its salts in the local treatment of trophic disorders
ATE205394T1 (de)	2001-09-15	Lektinkonzentrate aus mistelextrakten und entsprechende standardisierte, stabilisierte mistellektinpräparate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und deren verwendung zur erhöhung der natürlichen immunresistenz und/oder in der tumor-therapie
DK575588D0 (da)	1988-10-14	Farmaceutiske praeparater til behandling af obstruktive luftvejssygdomme
FI891357A0 (fi)	1989-03-22	Menetelmä valmistaa salisyylihappopitoista ainetta hilseileviä ihosairauksia vastaan
CN1142378A (zh)	1997-02-12	一种精神病治疗药剂
DE3268159D1 (en)	1986-02-06	Medicaments based on algae, and formulations thereof
EP0158880A3 (en)	1986-01-08	Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
ZA837972B (en)	1984-11-28	Method of analgesic treatment and pharmaceutical compositions
Sweeney et al.	1993	Healing a child's spirit through play therapy: A scriptural approach to treating children.
JPS5585526A (en)	1980-06-27	Remedy for allergic disease
PT100155A (pt)	1993-05-31	Uso de compostos analogos da camptotecina na obtencao de um medicamento para uso no tratamento do carcinoma das celulas nao pequenas do pulmao e composicoes farmaceuticas
Schenk et al.	1980	Controlled trial of carbenoxolone sodium vs. cimetidine in duodenal ulcer
ATE66375T1 (de)	1991-09-15	Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung.
Zachariah	1984	Effective penetration of doxycycline into the serum and aqueous humor

Legal Events

Date	Code	Title	Description
1990-10-15	AHB	Application shelved due to non-payment